Lista de obras - Franco Scaldaferri - Dominio Público Uruguay

Acute refractory intestinal pseudo-obstruction in MELAS: efficacy of prucalopride

artículo científico publicado en 2014

Anorectal function and quality of life in IBD patients with a perianal complaint

scientific article published on 18 October 2019

Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression?

artículo científico publicado en 2013

Bacillus clausii and gut homeostasis: state of the art and future perspectives.

artículo científico publicado en 2016

Bacterial flora as a cause or treatment of chronic diarrhea.

artículo científico publicado en 2012

Bacteriocins and Bacteriophages: Therapeutic Weapons for Gastrointestinal Diseases? ⬇️

artículo científico publicado en 2019

Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab.

artículo científico publicado en 2017

Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients undergoing anti-TNFα therapy

artículo científico publicado en 2020

Can We Predict the Efficacy of Anti-TNF-α Agents?

artículo científico publicado en 2017

Caspase-3 inhibits the growth of breast cancer cells independent of protease activity.

artículo científico publicado en 2005

Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment

scientific article published on 23 September 2020

Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum.

artículo científico publicado en 2016

Commensal Clostridia: leading players in the maintenance of gut homeostasis.

artículo científico

Commentary to "Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease"

scientific article published on 01 July 2019

Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterography.

artículo científico publicado en 2014

Considering gut microbiota disturbance in the management of Helicobacter pylori infection

scientific article published on 07 August 2018

Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease.

artículo científico publicado en 2007

Dietary magnesium: the magic mineral that protects from colon cancer?

artículo científico publicado en 2015

Direct effect of infliximab on intestinal mucosa sustains mucosal healing: exploring new mechanisms of action.

artículo científico publicado en 2015

Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis

artículo científico publicado en 2016

Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis.

artículo científico publicado en 2012

Endoscopic ultrasound-guided fine-needle tissue acquisition from a subepithelial lesion in the distal ileum using the forward-viewing echoendoscope

scientific article published on 07 May 2014

Enterography CT without and with water enema in patients with Crohn's disease: Results from a comparative observational study in comparison with endoscopy.

artículo científico publicado en 2015

European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies

artículo científico

European consensus conference on faecal microbiota transplantation in clinical practice.

artículo científico publicado en 2017

Exploring Bacteroidetes: Metabolic key points and immunological tricks of our gut commensals

scientific article published on 20 March 2018

Fecal microbiota transplantation in inflammatory bowel disease: beyond the excitement

artículo científico publicado en 2014

Fecal transplantation for ulcerative colitis: current evidence and future applications

artículo científico publicado en 2020

Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition ⬇️

artículo científico publicado en 2019

Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD?

artículo científico publicado en 2014

Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders?

artículo científico publicado en 2017

Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease.

artículo científico publicado en 2016

Gut Virome and Inflammatory Bowel Disease

artículo científico publicado en 2016

Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility

artículo científico publicado en 2013

Haemostatic system in inflammatory bowel diseases: new players in gut inflammation.

artículo científico publicado en 2011

Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease.

artículo científico publicado en 2005

IL-13Rα2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis.

artículo científico publicado en 2014

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre

artículo científico publicado en 2020

Impact of the Trophic Effects of the Secretome From a Multistrain Probiotic Preparation on the Intestinal Epithelia

scientific article published on 10 December 2020

Infliximab does not increase colonic cancer risk associated to murine chronic colitis.

artículo científico publicado en 2016

Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice.

artículo científico publicado en 2013

Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine

artículo científico publicado en 2015

Mesenchymal Stem Cells in IBD: unMaSCing Their Therapeutic Mechanisms.

artículo científico publicado en 2015

Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors?

artículo científico publicado en 2010

Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn's Disease

artículo científico publicado en 2018

Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide.

scientific article published on 03 January 2017

Origin of celiac disease: how old are predisposing haplotypes?

artículo científico publicado en 2012

Palaeodiet reconstruction in a woman with probable celiac disease: a stable isotope analysis of bone remains from the archaeological site of Cosa (Italy).

artículo científico publicado en 2014

Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives.

artículo científico

Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing

artículo científico

Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases

artículo científico publicado en 2012

Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing.

artículo científico publicado en 2011

Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome.

artículo científico publicado en 2015

Rifaximin for the treatment of irritable bowel syndrome - a drug safety evaluation.

artículo científico publicado en 2016

Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update

artículo científico publicado en 2016

Sustainability of Endovenous Iron Deficiency Anaemia Treatment: Hospital-Based Health Technology Assessment in IBD Patients.

artículo científico publicado en 2017

The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin.

artículo científico publicado en 2016

The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications

artículo científico publicado en 2020

The gastrointestinal microbiome - functional interference between stomach and intestine.

artículo científico publicado en 2014

The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center

artículo científico publicado en 2020

The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease.

artículo científico publicado en 2009

The use of single balloon enteroscopy in Crohn's disease and its impact on clinical outcome

artículo científico publicado en 2018

Therapy experiences and preferences among patients with anemia: Results of a cross-sectional survey among Italian patients with inflammatory bowel disease.

artículo científico

Towards a disease-associated common trait of gut microbiota dysbiosis: The pivotal role of Akkermansia muciniphila

artículo científico publicado en 2020

Use and indications of cholestyramine and bile acid sequestrants.

scientific article published on 08 July 2011

Usefulness of contrast-enhanced ultrasound (CEUS) in Inflammatory Bowel Disease (IBD)

artículo científico publicado en 2018

VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.

artículo científico publicado en 2008

Validation of an LC-MS/MS Method for Urinary Lactulose and Mannitol Quantification: Results in Patients with Irritable Bowel Syndrome

artículo científico publicado en 2016

[Microbiota and inflammatory bowel disease: an update.]

scientific article published on 01 December 2018

for the Treatment of Acute Diarrhea in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

artículo científico publicado en 2018

Lista de obras de Franco Scaldaferri

Acute refractory intestinal pseudo-obstruction in MELAS: efficacy of prucalopride

Anorectal function and quality of life in IBD patients with a perianal complaint

Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression?

Bacillus clausii and gut homeostasis: state of the art and future perspectives.

Bacterial flora as a cause or treatment of chronic diarrhea.

Bacteriocins and Bacteriophages: Therapeutic Weapons for Gastrointestinal Diseases? ⬇️

Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab.

Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients undergoing anti-TNFα therapy

Can We Predict the Efficacy of Anti-TNF-α Agents?

Caspase-3 inhibits the growth of breast cancer cells independent of protease activity.

Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment

Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum.

Commensal Clostridia: leading players in the maintenance of gut homeostasis.

Commentary to "Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease"

Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterography.

Considering gut microbiota disturbance in the management of Helicobacter pylori infection

Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease.

Dietary magnesium: the magic mineral that protects from colon cancer?

Direct effect of infliximab on intestinal mucosa sustains mucosal healing: exploring new mechanisms of action.

Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis

Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis.

Endoscopic ultrasound-guided fine-needle tissue acquisition from a subepithelial lesion in the distal ileum using the forward-viewing echoendoscope

Enterography CT without and with water enema in patients with Crohn's disease: Results from a comparative observational study in comparison with endoscopy.

European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies

European consensus conference on faecal microbiota transplantation in clinical practice.

Exploring Bacteroidetes: Metabolic key points and immunological tricks of our gut commensals

Fecal microbiota transplantation in inflammatory bowel disease: beyond the excitement

Fecal transplantation for ulcerative colitis: current evidence and future applications

Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition ⬇️

Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD?

Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders?

Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease.

Gut Virome and Inflammatory Bowel Disease

Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility

Haemostatic system in inflammatory bowel diseases: new players in gut inflammation.

Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease.

IL-13Rα2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis.

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre

Impact of the Trophic Effects of the Secretome From a Multistrain Probiotic Preparation on the Intestinal Epithelia

Infliximab does not increase colonic cancer risk associated to murine chronic colitis.

Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice.

Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine

Mesenchymal Stem Cells in IBD: unMaSCing Their Therapeutic Mechanisms.

Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors?

Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn's Disease

Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide.

Origin of celiac disease: how old are predisposing haplotypes?

Palaeodiet reconstruction in a woman with probable celiac disease: a stable isotope analysis of bone remains from the archaeological site of Cosa (Italy).

Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives.

Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing

Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases

Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing.

Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome.

Rifaximin for the treatment of irritable bowel syndrome - a drug safety evaluation.

Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update

Sustainability of Endovenous Iron Deficiency Anaemia Treatment: Hospital-Based Health Technology Assessment in IBD Patients.

The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin.

The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications

The gastrointestinal microbiome - functional interference between stomach and intestine.

The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center

The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease.

The use of single balloon enteroscopy in Crohn's disease and its impact on clinical outcome

Therapy experiences and preferences among patients with anemia: Results of a cross-sectional survey among Italian patients with inflammatory bowel disease.

Towards a disease-associated common trait of gut microbiota dysbiosis: The pivotal role of Akkermansia muciniphila

Use and indications of cholestyramine and bile acid sequestrants.

Usefulness of contrast-enhanced ultrasound (CEUS) in Inflammatory Bowel Disease (IBD)

VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.

Validation of an LC-MS/MS Method for Urinary Lactulose and Mannitol Quantification: Results in Patients with Irritable Bowel Syndrome

[Microbiota and inflammatory bowel disease: an update.]

for the Treatment of Acute Diarrhea in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials